517 related articles for article (PubMed ID: 29172863)
1. Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Forastiere AA; Ismaila N; Lewin JS; Nathan CA; Adelstein DJ; Eisbruch A; Fass G; Fisher SG; Laurie SA; Le QT; O'Malley B; Mendenhall WM; Patel S; Pfister DG; Provenzano AF; Weber R; Weinstein GS; Wolf GT
J Clin Oncol; 2018 Apr; 36(11):1143-1169. PubMed ID: 29172863
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer.
; Pfister DG; Laurie SA; Weinstein GS; Mendenhall WM; Adelstein DJ; Ang KK; Clayman GL; Fisher SG; Forastiere AA; Harrison LB; Lefebvre JL; Leupold N; List MA; O'Malley BO; Patel S; Posner MR; Schwartz MA; Wolf GT
J Clin Oncol; 2006 Aug; 24(22):3693-704. PubMed ID: 16832122
[TBL] [Abstract][Full Text] [Related]
3. Decision making in advanced larynx cancer: An evidenced based review.
Eskander A; Blakaj DM; Dziegielewski PT
Oral Oncol; 2018 Nov; 86():195-199. PubMed ID: 30409301
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
Choi YS; Park SG; Song EK; Cho SH; Park MR; Park KU; Lee KH; Song IC; Lee HJ; Jo DY; Kim S; Yun HJ;
Head Neck; 2016 Aug; 38(8):1271-7. PubMed ID: 27043228
[TBL] [Abstract][Full Text] [Related]
5. Total Laryngectomy Versus Larynx Preservation for T4a Larynx Cancer: Patterns of Care and Survival Outcomes.
Grover S; Swisher-McClure S; Mitra N; Li J; Cohen RB; Ahn PH; Lukens JN; Chalian AA; Weinstein GS; O'Malley BW; Lin A
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):594-601. PubMed ID: 26068492
[TBL] [Abstract][Full Text] [Related]
6. Organ preservation for advanced larynx cancer: A review of chemotherapy and radiation combination strategies.
Bonomi MR; Blakaj A; Blakaj D
Oral Oncol; 2018 Nov; 86():301-306. PubMed ID: 30409316
[TBL] [Abstract][Full Text] [Related]
7. Organ preservation surgery for patients with T4a laryngeal cancer.
Zhang C; Zhu M; Chen D; Chen S; Zheng H
Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1601-1606. PubMed ID: 29610957
[TBL] [Abstract][Full Text] [Related]
8. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
9. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
10. Treatment Selection for T3/T4a Laryngeal Cancer: Chemoradiation Versus Primary Surgery.
Timme DW; Jonnalagadda S; Patel R; Rao K; Robbins KT
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):845-51. PubMed ID: 25991835
[TBL] [Abstract][Full Text] [Related]
11. Oncological and functional outcomes in T3 and T4 laryngeal cancer patients: choice for larynx preservation or total laryngectomy based on expected laryngeal function.
Nobacht A; Meijer TWH; Oosting SF; van der Vegt B; Wedman J; Halmos GB; Plaat BEC
J Laryngol Otol; 2024 Jun; 138(6):672-678. PubMed ID: 38235588
[TBL] [Abstract][Full Text] [Related]
12. Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.
Lefebvre JL; Ang KK;
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1293-303. PubMed ID: 19306746
[TBL] [Abstract][Full Text] [Related]
13. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
[TBL] [Abstract][Full Text] [Related]
14. One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?
Nakayama M; Miyamoto S; Seino Y; Okamoto T; Kano K; Hasebe M; Okamoto M
Jpn J Clin Oncol; 2015 Aug; 45(8):732-7. PubMed ID: 25981622
[TBL] [Abstract][Full Text] [Related]
15. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
[TBL] [Abstract][Full Text] [Related]
16. Treatment of early-stage laryngeal cancer: A comparison of treatment options.
Baird BJ; Sung CK; Beadle BM; Divi V
Oral Oncol; 2018 Dec; 87():8-16. PubMed ID: 30527248
[TBL] [Abstract][Full Text] [Related]
17. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.
Jones TM; De M; Foran B; Harrington K; Mortimore S
J Laryngol Otol; 2016 May; 130(S2):S75-S82. PubMed ID: 27841116
[TBL] [Abstract][Full Text] [Related]
18. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
19. Failed larynx preservation and survival in patients with advanced larynx cancer.
Nocon CC; Yesensky J; Ajmani GS; Bhayani MK
Am J Otolaryngol; 2019; 40(4):542-546. PubMed ID: 31036417
[TBL] [Abstract][Full Text] [Related]
20. From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.
Spector ME; Rosko AJ; Swiecicki PL; Chad Brenner J; Birkeland AC
Oral Oncol; 2018 Nov; 86():200-205. PubMed ID: 30409302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
